Drug recall · September 9, 2026
Trokendi XR recall
Why: Failed dissolution specifications.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-102-30.
- Lots / codes
Lot# 2145283, Exp Date: 31-Mar-2030.
- Quantity
- 11304 bottles
- Company
- Supernus Pharmaceuticals, Inc., Rockville, MD
- Distribution
- US Nationwide.
- Initiated
- August 31, 2026 · Voluntary: Firm initiated
- Classified
- September 3, 2026
- Reported
- September 9, 2026
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Trokendi
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.